Lithium prices rise as Chinese companies return to the market, signaling the end of a slide. Short-term restocking and long-term EV demand expected to drive prices up.
Gainers
Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 114% to $1.47. Palisade Bio transformed GI-focused pipeline through exclusive worldwide licensing agreement with Giiant Pharma, Inc. for multiple oral drug candidates targeting inflammatory bowel disease.
American Lithium Corp. ("American Lithium" or the "Company") (TSXV:LI, NASDAQ:AMLI, Frankfurt:5LA1)))) announces that it has decided to advance the next phase of work at Macusani within American Lithium, and as a result